Skip to Main Content

Advertisement

Skip Nav Destination

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

Blood Adv (2019) 3 (10): 1568–1573.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement